Cell Secretome: Basic Insights and Therapeutic Opportunities for CNS Disorders
Open accessThe DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Abstract
Transplantation of stem cells, in particular mesenchymal stem cells (MSCs), stands as a promising therapy for trauma, stroke or neurodegenerative conditions such as spinal cord or traumatic brain injuries (SCI or TBI), ischemic stroke (IS), or Parkinson’s disease (PD). Over the last few years, cell transplantation-based approaches have started to focus on the use of cell byproducts, with a strong emphasis on cell secretome. Having this in mind, the present review discusses the current state of the art of secretome-based therapy applications in different central nervous system (CNS) pathologies. For this purpose, the following topics are discussed: (1) What are the main cell secretome sources, composition, and associated collection techniques; (2) Possible differences of the therapeutic potential of the protein and vesicular fraction of the secretome; and (3) Impact of the cell secretome on CNS-related problems such as SCI, TBI, IS, and PD. With this, we aim to clarify some of the main questions that currently exist in the field of secretome-based therapies and consequently gain new knowledge that may help in the clinical application of secretome in CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Number of publications per year of cell-, secretome-, or exosome-based therapies on central nervous system (CNS) disorders (Parkinson’s disease (PD), spinal cord injury (SCI), traumatic brain injury (TBI) and ischemic stroke (IS)). An electronic research on PubMed database for literature describing cell-, secretome-, and exosome-based therapies was performed on 18 January 2019 using the following keywords: (cell OR cellular OR stem OR cells) AND (transplantation OR transplant OR “Co-Transplantation” OR Cotransplantation OR engraft OR engraftment OR graft OR grafts) AND (therapy OR therapies OR therapeutics OR therapeutic) NOT Review [Publication Type] AND (“spinal cord injury” or “brain injury” or stroke or parkinson) AND (primates OR mice OR mouse OR rat OR rats OR rodent OR “in vivo” OR “clinical Trials” OR humans) for cell-based therapies and (conditioned medium OR conditioned media OR secretory OR “trophic factors” OR Exosomes OR vesicles OR microvesicles OR vesicular OR “Extracellular vesicles” OR “nanovesicles” OR “exosomal”) AND (therapy OR therapies OR therapeutics OR therapeutic) NOT Review[Publication Type] AND (“spinal cord injury” or “brain injury” or stroke or parkinson) AND (primates OR mice OR mouse OR rat OR rats OR rodent OR “in vivo” OR “clinical Trials” OR humans) for secretome- and exosome-based therapies. The search retrieved 3676 articles for cell-based therapies and 682 articles for secretome- and exosome-based therapies. Data extraction was independently performed by two researchers.](https://figures.cochat.ai/paper-figures/a37d098deb8648058a26f97d504e4a48/cell-secretome-basic-insights-and-therapeutic-opportunities-for-cns-disorders-figure-1.jpg)
![Figure 2 Mesenchymal stem cell secretome composition and their main effects on the CNS. On their soluble fraction (red circles), MSC secretome contains cytokines, chemokines, growth factors, and glycoproteins. On their vesicular fractions (orange circles), the exosomes and microvesicles contain essentially microRNAs. Both the soluble and the vesicular fractions may act on distinct damaged cells of the nervous system, promoting their survival, angiogenesis, neurite outgrowth, and immunomodulation. This information is based on the articles [85,86].](https://figures.cochat.ai/paper-figures/6a9797bee1d545a395bd5dd96ec7519b/cell-secretome-basic-insights-and-therapeutic-opportunities-for-cns-disorders-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It involves the in vitro modulation of the secretome produced by MSC by exposing these cells to specific factors that usually mimic the tissue damage microenvironment [73], namely to hypoxia, inflammatory or disease-specific cytokines and/or pharmacological compounds, or even by using 3-dimensional (3D) cell culture systems [54], [120], [121].”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [54]
The cited source says what the claim attributes to it.
In the citing paper
“Multiple studies exploring strategies of modulating environmental factors with the potential to enhance the beneficial effects of secretome-contained biomolecules have been performed, namely via preconditioning [18], [54], [120].”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926 · cited 1×
“biologic content on cell cytoplasm, finally inducing angiogenesis [91,92] and neurite outgrowth [93,94] and regulating inflammatory responses [95,96].”
BackgroundMathieu, M., Martin-Jaular, L., Lavieu, G., & Théry, C. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0250-9 · Cited by 3,737 · cited 1×
“However, the vesicular fraction by itself could also constitute a powerful therapeutic approach since EVs are similarly involved in intercellular communication and may contain all the signals required for a successful contact [101].”
BackgroundEstimating the global incidence of traumatic brain injury
Dewan, M. C., Rattani, A., Gupta, S., Baticulon, R. E., Hung, Y.-C., Punchak, M., Agrawal, A., Adeleye, A. O., Shrime, M. G., Rubiano, A. M., et al. (2019) · Journal of Neurosurgery · doi:10.3171/2017.10.jns17352 · Cited by 3,291
Regeneration beyond the glial scar
Silver, J., & Miller, J. H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1326 · Cited by 3,078 · cited 1×
“, cellular dysfunction or death, overactivation of immune cells, production of reactive oxygen species or proteoglycans, and glial scar formation) that exacerbate the primary insult [9,10].”
BackgroundMesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992 · cited 1×
“Indeed, factors such as GDNF, NGF, HGF, VEGF, IGF-1 and 2, chemokine (C-X-C motif) ligand (CXCL 16), IL-6 and 10, TGF β1, and MCP-1 have been related to the neuro- and immunoregulatory character of MSC secretome [63,87,99,100].”
BackgroundSecretion of angiogenic and antiapoptotic factors by human adipose stromal cells
Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C. J., Bovenkerk, J. E., Pell, C. L., Johnstone, B. H., Considine, R. V., & March, K. L. (2004) · Circulation · doi:10.1161/01.cir.0000121425.42966.f1 · Cited by 2,269 · cited 1×
“Similarly to what has been reported for BM-MSCs, growth factors such as vascular endothelial growth factor (VEGF), glial-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), hepatocyte growth factor (HGF), fibroblast growth factor (FGF), nerve growth factor (NGF), insulin-like growth factors 1…”
BackgroundThe prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009
Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930 · cited 1×
“, messenger RNAs and microRNAs) and small proteins are secreted through membranal fusion to the extracellular space [89,90].”
Background
Research works printed but not linked: 1
- Chang, 2013, Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury, Clin. Sci., 124, 165, 10.1042/cs20120226 · DOI · Paper page
Cited by
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
“…have an important role in mediating the regenerative and immunomodulatory properties of MSCs [51,52], a completely consensus is not established [53,54], with some data showing that the total MSC-secretome and MSC-EV-free fraction had better immunomodulatory effects when compared with MSC-EVs…”
InfluentialDental Pulp Stem Cell-Derived Secretome and Its Regenerative Potential
Bar, J. K., Lis-Nawara, A., & Grelewski, P. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112018 · Cited by 142
Pathophysiology and Therapeutic Approaches for Spinal Cord Injury
Lima, R., Monteiro, A., Salgado, A. J., Monteiro, S., & Silva, N. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213833 · Cited by 142
Self-citationZhou, X., Chu, X., Yuan, H., Qiu, J., Zhao, C., Xin, D., Li, T., Ma, W., Wang, H., Wang, Z., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108818 · Cited by 111
Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges
Li, W., Shi, L., Hu, B., Hong, Y., Zhang, H., Li, X., & Zhang, Y. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.628940 · Cited by 115
“They can be isolated from almost all tissues in mammals including bone marrow (BM), adipose tissue or other tissues (Pinho et al., 2020) and are easy to culture and effectively expand.”
BackgroundHigh-throughput spatiotemporal monitoring of single-cell secretions via plasmonic microwell arrays
Ansaryan, S., Liu, Y., Li, X., Economou, A. M., Eberhardt, C. S., Jandus, C., & Altug, H. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01017-1 · Cited by 101
Omics-Based Investigations of Breast Cancer
Neagu, A.-N., Whitham, D., Bruno, P. S., Morrissiey, H., Darie, C. A., & Darie, C. C. (2023) · Molecules · doi:10.3390/molecules28124768 · Cited by 87
Russo, V., Khatib, M. E., Prencipe, G., Citeroni, M. R., Faydaver, M., Mauro, A., Berardinelli, P., Cerveró-Varona, A., Haidar-Montes, A. A., Turriani, M., et al. (2022) · Cells · doi:10.3390/cells11030434 · Cited by 89
Stem Cells: Present Understanding and Prospects for Regenerative Dentistry
Inchingolo, A. M., Inchingolo, A. D., Nardelli, P., Latini, G., Trilli, I., Ferrante, L., Malcangi, G., Palermo, A., Inchingolo, F., & Dipalma, G. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15100308 · Cited by 63
Mechanisms of Stem Cell Therapy in Spinal Cord Injuries
Shinozaki, M., Nagoshi, N., Nakamura, M., & Okano, H. (2021) · Cells · doi:10.3390/cells10102676 · Cited by 62
“However, neurotrophic factors secreted by MSCs have been shown to exert a therapeutic effect on the lesion [23,24].”
BackgroundBarbosa, M., Gomes, C., Sequeira, C., Gonçalves-Ribeiro, J., Pina, C. C., Carvalho, L. A., Moreira, R., Vaz, S. H., Vaz, A. R., & Brites, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634355 · Cited by 54
Huang, J., Kin Pong, U., Yang, F., Ji, Z., Lin, J., Weng, Z., Tsang, L. L., Merson, T. D., Ruan, Y. C., Wan, C., et al. (2021) · Theranostics · doi:10.7150/thno.57234 · Cited by 51
“Interestingly, MSCs secrete a plethora of growth factors and cytokines known to influence neuronal survival, differentiation, neurite outgrowth and immunomodulation [11, 12].”
BackgroundGavasso, S., Kråkenes, T., Olsen, H., Evjenth, E. C., Ytterdal, M., Haugsøen, J. B., & Kvistad, C. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031365 · Cited by 48
“The soluble fraction contains cytokines and chemokines, such as IL-10, IL6 and CXCL-10 and growth factors, including GDNF, FGF, IGF and BDNF [20].”
BackgroundMesenchymal stromal cell secretome for traumatic brain injury: Focus on immunomodulatory action
Pischiutta, F., Caruso, E., Cavaleiro, H., Salgado, A. J., Loane, D. J., & Zanier, E. R. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114199 · Cited by 47
Self-citationXiong, Y., Mahmood, A., & Chopp, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374143 · Cited by 46
“…therapeutic effects of MSCs may be attributed to their generation and release of extracellular vesicles (EVs) but other molecules secreted by MSCs are also associated with the MSC therapeutic effects (Eleuteri and Fierabracci, 2019; Ahangar et al., 2020; Pinho et al., 2020; Muhammad et al., 2022).”
BackgroundHodgson‐Garms, M., Moore, M., Martino, M. M., Kelly, K., & Frith, J. E. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-024-00382-y · Cited by 50
Pinho, A. G., Cibrão, J. R., Lima, R., Gomes, E. D., Serra, S. C., Lentilhas-Graça, J., Ribeiro, C., Lanceros-Méndez, S., Teixeira, F. G., Monteiro, S., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.113989 · Cited by 40
Self-citationSecretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
Mishra, D., & Banerjee, D. (2023) · Cells · doi:10.3390/cells12040628 · Cited by 40
Cell Secretome Strategies for Controlled Drug Delivery and Wound-Healing Applications
Ibrahim, R., Mndlovu, H., Kumar, P., Adeyemi, S. A., & Choonara, Y. E. (2022) · Polymers · doi:10.3390/polym14142929 · Cited by 43
Secretome Analysis: Reading Cellular Sign Language to Understand Intercellular Communication
Wu, W., & Krijgsveld, J. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100692 · Cited by 42
“For instance, mesenchymal stem cell secretomes have been explored in therapies for trauma, stroke, or neurodegenerative conditions such as spinal cord or traumatic brain injuries, ischemic stroke, and Parkinson ’ s disease (15).”
BackgroundAdipose-derived stem cell secretome as a cell-free product for cutaneous wound healing
Ajit, A., & Gopalankutty, I. A. (2021) · 3 Biotech · doi:10.1007/s13205-021-02958-7 · Cited by 35
Silva, K. D., Kumar, P., & Choonara, Y. E. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.13251 · Cited by 34
“15 As such, attention has shifted towards the cell-secretome.”
Mesenchymal Stromal Cells in Ischemic Brain Injury
Brooks, B., Ebedes, D. M., Usmani, A., Gonzales-Portillo, J. V., Gonzales-Portillo, D., & Borlongan, C. V. (2022) · Cells · doi:10.3390/cells11061013 · Cited by 31
Marote, A., Santos, D. J., Mendes-Pinheiro, B., Serre-Miranda, C., Anjo, S. I., Vieira, J., Ferreira-Antunes, F., Correia, J. S., Borges-Pereira, C., Pinho, A. G., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10453-6 · Cited by 30
Self-citationMendes-Pinheiro, B., Campos, J., Marote, A., Soares‐Cunha, C., Nickels, S., Monzel, A. S., Cibrão, J. R., Loureiro‐Campos, E., Serra, S. C., Barata‐Antunes, S., et al. (2023) · Cells · doi:10.3390/cells12212565 · Cited by 26
“Furthermore, the temporal dynamics of our injury model indicate that the effect of the secretome may derive from pleiotropic mechanisms [9,10].”
BackgroundSelf-citationThe Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis
Kråkenes, T., Sandvik, C. E., Ytterdal, M., Gavasso, S., Evjenth, E. C., Bø, L., & Kvistad, C. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910292 · Cited by 25
“…PGE2, CXCL-10, glial-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), hepatocyte growth factor (HGF), nerve growth factor (NGF) and insulin-like growth factors 1 and 2 (IGF-1 and IGF-2) [28,29].”
BackgroundUrine-Derived Stem Cells for Epithelial Tissues Reconstruction and Wound Healing
Yin, X., Li, Q., McNutt, P. M., & Zhang, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081669 · Cited by 25
Muhammad, S. A., Abbas, A. Y., Imam, M. U., Saidu, Y., & Bilbis, L. S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02759-w · Cited by 25
Yarahmadi, A., Dorri Giv, M., Hosseininejad, R., Rezaie, A., Mohammadi, N., Afkhami, H., & Farokhi, A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1472679 · Cited by 21
Li, R., Duan, W., Feng, T., Gu, C., Zhang, Q., Long, J., Huang, S., & Chen, L. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00831-8 · Cited by 21
“They are becoming a potential therapeutic approach for regenerative medicine [8–10].”
BackgroundSheikhi, K., Ghaderi, S., Firouzi, H., Rahimibarghani, S., Shabani, E., Afkhami, H., & Yarahmadi, A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1517369 · Cited by 20
Singh, N., Choonara, Y. E., & Kumar, P. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.04.005 · Cited by 21
“Hybridization is detected using a one colour fl uorescent light for the detection of gene expression [50], spotted arrays use a two-colour system to measure gene expression [1].”
InfluentialLi, J., Liu, Y., Zhang, R., Yang, Q., Xiong, W., He, Y., & Ye, Q. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03774-5 · Cited by 21
“Exos act by injecting their contents straight into cells, avoiding the requirement for specialized receptor expression [122, 128].”
BackgroundNazarinia, D., Dolatshahi, M., Faezi, M., Maleki, S. N., & Aboutaleb, N. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.101938 · Cited by 21
Yang, Z., Liang, Z., Rao, J., Lin, F., Lin, Y., Xu, X., Wang, C., & Chen, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371376 · Cited by 19
“The majority of the studies used MSCs derived from the bone Research Article marrow ( n = 42), a portion from the placenta ( n = 10), and a small portion from fat (n = 5) and umbilical cord ( n = 3).”
Lentilhas-Graça, J., Santos, D. J., Afonso, J. L., Monteiro, A., Pinho, A. G., Mendes, V. M., Dias, M. S., Gomes, E. D., Lima, R., Fernandes, L. S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1354479 · Cited by 19
Self-citationMesenchymal-Stromal-Cell-Conditioned Media and Their Implication for Osteochondral Regeneration
Ivanisova, D., Boháč, M., Culenova, M., Smolinská, V., & Danišovič, Ľ. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109054 · Cited by 17
Barbosa, M., Santos, M., de Sousa, N., Duarte-Silva, S., Vaz, A. R., Salgado, A. J., & Brites, D. (2022) · Biomedicines · doi:10.3390/biomedicines10092120 · Cited by 14
Self-citationKatta, M., Mathew, B. A., Chaturvedi, P., Ludhiadch, A., & Munshi, A. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06356-6 · Cited by 16
Du, Y., Zong, M., Guan, Q., Huang, Z., Zhou, L., Cai, J., da Roza, G., Wang, H., Qi, H., Lu, Y., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02473-9 · Cited by 12
Ramakrishnan, P., Jalaludeen, A. M., Vinayagam, S., Gnanasekaran, L., Thirumurugan, D., Rajamohan, R., & Sundaram, T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147919 · Cited by 13
Gauthier, T., Martin-Rodriguez, O., Chagué, C., Daoui, A., Ceroi, A., Varin, A., Bonnefoy, F., Valmary‐Degano, S., Couturier, M., Behlke, S., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02994-5 · Cited by 11
“Secretome-based drugs represent a new therapeutic modality [59] and have gained momentum in recent years, as they are preserving the potential of the paracrine action of cellular therapy, while overcoming the survival or erroneous differentiation complications of transplanted cells in the host…”
BackgroundStimuli-Responsive Substrates to Control the Immunomodulatory Potential of Stromal Cells
Castilla‐Casadiego, D. A., Loh, D. H., Pineda‐Hernandez, A., & Rosales, A. M. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.4c00835 · Cited by 9
Biomaterial engineering for cell transplantation
Samadi, A., Moammeri, A., Azimi, S., Bustillo-Perez, B. M., & Mohammadi, M. R. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.213775 · Cited by 9
Unlocking the potential of extracellular vesicles: one stimulus away from clinical implementation
Silva, R. M., Azevedo, A. M., Bonifácio, V. D. B., Fernandez-Becerra, C., & Pinto, S. N. (2025) · Biomaterials Science · doi:10.1039/d5bm01091h · Cited by 10
Fadilah, N. I. M., Fauzi, M. B., & Maarof, M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060767 · Cited by 7
“Conditioned media generally refers to the spent media that is used for culturing specific types of cells under a specific condition and time that contains proteins or small molecules secreted by the cells [8,9].”
BackgroundRasouli, M., Alavi, M., D’Angelo, A., Sobhani, N., Roudi, R., & Safari, F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113265 · Cited by 10
Rieux, A. D. (2021) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2021.101460 · Cited by 8
Comparative and pharmacological investigation of bEVs from eight Lactobacillales strains
Park, S. B., Mok, J., Yu, H.-M., An, H.-J., Choi, G.-H., Lee, Y.-S., Kwon, K.-J., Choi, S.-P., Kim, K., Kim, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-12873-z · Cited by 6
Campos, J., Sampaio‐Marques, B., Santos, D. J., Barata‐Antunes, S., Ribeiro, M. A., Serra, S. C., Pinho, T. S., Canto-Gomes, J., Marote, A., Cortez, M., et al. (2024) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-024-00679-5 · Cited by 6
Self-citationCibrão, J. R., Armada, M., Lima, M. F., Vidinha‐Mira, A., Campos, J., Pinho, T. S., Salgado, A. J., Ainla, A., & Silva, N. A. (2025) · BMC Biomedical Engineering · doi:10.1186/s42490-025-00090-8 · Cited by 8
Self-citationTeli, P., Nachanekar, A., Kale, V. P., & Vaidya, A. (2023) · Regenerative Medicine · doi:10.2217/rme-2022-0201 · Cited by 6
Swanson, W. B., & Mishina, Y. M. (2022) · Biocell · doi:10.32604/biocell.2022.018781 · Cited by 6
“The secretome, the composite milieu of cells’ secreted factors which includes: proteins, growth factors, and extracellular vesicles (EVs), has recently been identified as a critical driver of cell fate (Pinho et al., 2020).”
BackgroundCunningham, C. J., Enrich, M. V., Pickford, M. M., MacIntosh-Smith, W., & Huang, W. (2020) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2004080 · Cited by 6
“Given the vast array of cytokines, chemokines, growth factors and EVs present in the secretome, it is likely that a combination of mechanisms and mediators are involved [5].”
BackgroundInfluentialMesenchymal Stem Cell Secretome: A Potential Biopharmaceutical Component to Regenerative Medicine?
Araújo, B., Caridade-Silva, R., Domingues, S., Salgado, A. J., & Teixeira, F. G. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_46-1 · Cited by 4
Self-citationHambarsari, Y., Suroto, S., Mirawati, D. K., Soetrisno, S., Wasita, B., Widyaningsih, V., Pamungkasari, E. P., Subandi, S., Danuaji, R., Hamidi, B. L., et al. (2024) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2024.194976 · Cited by 4
“Mesenchymal stromal cell-derived secretomes, which includes the use of exosomes and EVs, represents a novel and promising approach in the treatment of AD, an progressive neurodegenerative condition marked by memory loss and cognitive impairment [57].”
Peruzzotti‐Jametti, L., & Pluchino, S. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221097958 · Cited by 4
Palha, A. T., LIMA, M. A. R., Carvalho, M., Campos, J., Sampaio‐Marques, B., & Salgado, A. J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07933-5 · Cited by 3
“Together, they have shown neuroprotective, angiogenic, anti-apoptotic and anti-inflammatory properties [99, 164].”
Self-citationMahmoudian, M., Alizadeh, S., Lotfi, D., Monfared, Y. K., Mahdipour, M., Trotta, F., Zakeri‐Milani, P., & Islambulchilar, Z. (2024) · Nanotoxicology · doi:10.1080/17435390.2024.2446553 · Cited by 4
“The cell secretome consists of many different biocomponents and is separated into two main fractions: the vesicular fraction, such as exosomes and cytokines, and the soluble fractions (Pinho et al. 2020).”
Secretome analysis of patient-derived glioblastoma cells for potential biomarker identification
Magalhães, M., Cabral, C., Costa, B. M., & Manadas, B. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99873-4.00015-3 · Cited by 4
Exploring the Secretome’s Biomarker and Analgesic Potential
Hershfield, M. R., Strain, M. M., Chavez, R., Priess, M., Mares, A., Gautam, A., Dimitrov, G., Yang, R., Trevino, A. V., Wells, C. K., et al. (2022) · American Journal of Psychiatry and Neuroscience · doi:10.11648/j.ajpn.20221002.12 · Cited by 3
(2024) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.2001001 · Cited by 3
Wound Healing Effect of PRP-Induced MSC Secretome Under High Glucose Conditions: An In Vitro Study
Murali, R., & Bhatt, A. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-024-00383-9 · Cited by 2
“It is known that a cell’s function is dependent on its secretome and also on the clues it gets through paracrine signalling from the microenvironment [19].”
The secretome from embryonic stem cell cardiomyogenesis: Same signals, different cellular feedbacks
Robert, A. W., & Stimamiglio, M. A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29907 · Cited by 2
Bansal, A., Singh, A., Nag, T. C., Sharma, D., Garg, B., Bhatla, N., Choudhury, S. D., & Ramakrishnan, L. (2023) · Biomedicines · doi:10.3390/biomedicines11051372 · Cited by 3
Shevela, Е. Y., Loginova, T. A., Munkuev, A. S., Volskaya, T. E., Sergeeva, S. A., Ращупкин, И. М., Kafanova, M. Y., Degtyareva, V. G., Sosnovskaya, A. V., Ostanin, A. A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113079 · Cited by 2
“These cells produce a large number of cytokines and growth factors that regulate the severity of the inflammatory response, on the one hand, and are involved in the “launch of” reparative processes, on the other hand [5–7].”
BackgroundDumingan, A., Malik, A., Rinendyaputri, R., Utama, H. A. N., Sunarno, S., Purwaningtyas, Y. R., Idrus, H. H., Noverina, R., Huda, F., & Faried, A. (2024) · Biota · doi:10.20414/jb.v17i1.492 · Cited by 4
Nanotechnology: A Promising Approach in Nerve Regeneration
Chaskar, A. C., Azmi, N., Tiwari, A., & Kaur, N. (2022) · Current Nanoscience · doi:10.2174/1573413718666220509125522 · Cited by 2
Mesenchymal Stem Cell Secretome: A Potential Biopharmaceutical Component to Regenerative Medicine
Araújo, B., Silva, R. C., Domingues, S., Salgado, A. J., & Teixeira, F. G. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_46 · Cited by 2
Self-citationCaramelo, I., Domingues, C., Mendes, V. M., Anjo, S. I., Geraldo, M., Cardoso, C. M. P., Grãos, M., & Manadas, B. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.26.609692 · Cited by 2
Secretome Profiling in Axon Regeneration: Emerging Techniques and Therapeutic Translation
Cabrera, M. D., Ramones, N., Moceri, I., & Bhattacharya, S. K. (2025) · Sensory Neuroscience · doi:10.1002/sen2.70009 · Cited by 1
Magnetically Actuated Cell Culture Platform for Controlling High‐Throughput Cyclic Strain
Stottlemire, B. J., Chakravarti, A. R., & Berkland, C. J. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202400466 · Cited by 1
Melchior, B., Browning, M., McCartan, R., Lai, C., Hahn-Townsend, C., Gratkowski, A., Morin, A., MULLAN, M. J., Crawford, F., Grifman, M., et al. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00843 · Cited by 1
“Combining DYRK1A inhibitors with biologics such as exosome-or secretome-based therapies may further enhance neuroprotection, reduce inflammation, and support tissue repair [49,50].”
Santo, S. D., & Widmer, H.-R. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.301007
“…from EPC and stem cells have displayed encouraging neurorestorative results in preclinical models of central nervous system degeneration (Maki et al., 2018; Pinho et al., 2020) but the translation to clinical applications warrants a better understanding of the composition of the paracrine factors.”
BackgroundResultInfluentialIchihashi, M., Tanaka, M., Iizuka, T., Narumi, N., Youko, S., Takahashi, H., Asami, U., Hiroko, T., Narumi, T., Nishikata, T., et al. (2020) · International Journal of Stem cell Research & Therapy · doi:10.23937/2469-570x/1410070
The essentials of stem cell-derived secretome in wound healing
Fadhilah, D. Y. N., & Sukmawati, D. (2023) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2023.16.2.0440 · Cited by 2
“It has advantages including overcoming the ethical barriers of cell transplantation, not causing complications of wrong differentiation of cells in recipient tissues and maintaining the paracrine action potential of cellular therapy [4].”
BackgroundInfluentialTHE CURRENT STATE OF STEM CELL THERAPY FOR SPINAL CORD INJURY AND OTHER SYSTEMIC INJURIES
Basiaga, B., Baczkowski, S., Żądecka-Kobiałka, K., Putra, A., Marchaj, M., Nowicka-Jasińska, M., Frączyk, P., Bieniek-Zając, S., Bednarz, K., Krawiec, K., et al. (2024) · Archiv Euromedica · doi:10.35630/2024/14/2.207
Sousa, C. S., Lima, R., Gomes, E. D., Silva, D., Cibrão, J. R., Pinho, T. S., Jorge, D., Afonso, J., Martins‐Macedo, J., Monteiro, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.02.601664
Self-citationConditioned media from dental pulp stem cells to counteract age-related macular degeneration
Carozza, G., Zerti, D., Pulcini, F., Lancia, L., Monache, S. D., Mattei, V., & Maccarone, R. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110167
Umbilical cord-derived secretome induces apoptosis and reduces proliferation in cancer cells
Awan, S. J., Manuwar, M., Shahzadi, M., Hafeez, S., & Kausar, H. (2025) · International Journal of Applied and Experimental Biology · doi:10.56612/ijaaeb.v1i1.116
Advanced Drug Delivery TechnologiesPreprint
Çetin, E. Ö., Erisik, D., TAŞKIRAN, A., Çalışkan, E. E., Demirtürk, E., AYDIN, Y. Ç., & Uyanıkgil, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5080254 · Cited by 1
Mesenchymal Stem Cells Secretome for Diabetic Wound
Lukas, D. V., Lheman, J., Hendrawan, S., & Tan, S. T. (2025) · Penerbit BRIN eBooks · doi:10.55981/brin.1128.c1298
Traumatic brain injury: basic cellular mechanisms and new approaches to therapy
Sudina, A. K., Grinchevskaia, L. R., Goldshtein, D. V., Fatkhudinov, T., & Salikhova, D. I. (2024) · RUDN Journal of Medicine · doi:10.22363/2313-0245-2024-28-1-246-255
Alavi, M., Safari, F., Asl, S. F., & Mansour‐Ghanaei, F. (2025) · Stem Cells International · doi:10.1155/sci/7434211
“These vesicles engage with target cells by binding to cellular receptors or delivering their cargo into the cell cytoplasm, triggering processes like angiogenesis, neurite outgrowth, and in fl ammatory responses [22, 23].”
Du, Y., Zong, M., Guan, Q., Huang, Z., Zhou, L., Cai, J., da Roza, G., Wang, H., Qi, H., Lu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14978325
Gauthier, T., Martin-Rodriguez, O., Chagué, C., Daoui, A., Ceroi, A., Varin, A., Bonnefoy, F., Valmary‐Degano, S., Couturier, M., Behlke, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24883580
Du, Y., Zong, M., Guan, Q., Huang, Z., Zhou, L., Cai, J., da Roza, G., Wang, H., Qi, H., Lu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14978331
Du, Y., Zong, M., Guan, Q., Huang, Z., Zhou, L., Cai, J., da Roza, G., Wang, H., Qi, H., Lu, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14978328
Cavaleiro, H. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Outgrowth Endothelial Cells (OECs): Cell-Based Therapy, Cell-Free Strategy, and Role of Senescence
Kadir, R. R. A. (2022) · Nottingham ePrints (University of Nottingham)
Armada, M. J. L. A. D. R. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Silva, D. I. F. D. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Marques, C. R. F. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Lesão da medula espinhal: poderá a recuperação ser alcançada através do baço?
Graça, J. C. L. D. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Moon, S.-H., Huh, Y. E., & Choi, H. J. (2026) · Future Pharmacology · doi:10.3390/futurepharmacol6010008
Besio, R., Maffioli, E., Palladino, E., Sala, A., Garibaldi, N., Izzi, V., Forlino, A., & Tedeschi, G. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71120
“It plays a crucial role in mediating cell- to-cell communication both locally and systemically to maintain the cellular physiological homeostasis while fluctuations in its composition are reported in pathological conditions [20, 21].”
Extracellular vesicles in neurodegenerative diseases
Singh, G., Prasad, S., Singh, C., & Singh, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36641-3.00008-5
Escobar, L. M., Bendahan, Z., Lugo, W., Calderon, E., Ramirez, L. E., Castaño, S., Castellanos, J. E., & González-Carrera, M. C. (2026) · International Journal of Dentistry · doi:10.1155/ijod/1123854
“Through this complex secreted milieu, DPSC_CM can mediate many of the paracrine and immunomodulatory effects attributed to DPSC, without the need to transplant living cells [14, 15].”
Mesenchymal stem cells and their secretome: a promising approach for Parkinson’s disease treatment
Zanjaniha, S., Moradi, H., Zahedi, P., Dashti, R., Rezaeirad, A., Hakimi, F., Parsaei, H., & Jafari, D. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01191-4
“…that the Mesenchymal Stem Cells derived (MSC-derived) secretome modulates critical pathological pathways linked to fundamental homeostatic processes, including cellular differentiation, proliferation, angiogenesis, and the regulation of inflammatory and oxidative stress responses [36, 133, 137].”
Hammad, B. A., Helal, M. E., Amin, L. E., Youssef, J. M., & El-Qashty, R. (2026) · BMC Oral Health · doi:10.1186/s12903-026-09337-9
“Therefore, using cell free therapy instead of cell-based treatment could be a better option as a new therapeutic opportunity in regenerative medicine [8].”
Metadata
- Authors
- Pinho, A. G., Cibrão, J. R., Silva, N. A., Monteiro, S., & Salgado, A. J.
- Affiliations
- University of Minho (PT)
- Corresponding author
- Salgado, António J.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2020-02-20
- Volume
- 13
- Issue
- 2
- Pages
- 31
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC7169381
- OpenAlex
- W3007972554
- Cited by
- 94
- References
- 155
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 18 · 2023: 15 · 2022: 17 · 2021: 12 · 2020: 5
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
- Funders
- FUNDAÇÃO PARA A CIÊNCIA E TECNOLOGIA, SANTA CASA NEUROSCIENCE AWARDS, NORTE 2020, FEDER, COMPETE (MC-04/17; CEECIND/04794/2017; CEECIND/01902/2017; POCI-01-0145-FEDER-007038; TUBITAK/0007/2014; POCI-01-0145-FEDER-029206, POCI-01-0145-FEDER-029751; NORTE-01-0145-FEDER-029968; NORTE-01-0145-FEDER-000013 and NORTE-01-0145-FEDER-000023)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Keywords
- secretome, mesenchymal stem cells, cell transplantation, extracellular vesicles, spinal cord injury, traumatic brain injury, ischemic stroke, Parkinson's disease, central nervous system disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.